3569 related articles for article (PubMed ID: 8267675)
21. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
[TBL] [Abstract][Full Text] [Related]
25. Absorption, distribution, metabolism and excretion of [14C]ebastine after repeated oral administration in rats.
Fujii T; Tanaka K; Matsumoto S; Hatoyama T; Nomura N; Tagawa M; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):538-43. PubMed ID: 7912072
[TBL] [Abstract][Full Text] [Related]
26. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
[TBL] [Abstract][Full Text] [Related]
27. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
[TBL] [Abstract][Full Text] [Related]
28. Absorption, distribution and excretion after oral administration of 14C-benidipine hydrochloride in rats and dogs.
Kobayashi H; Ohishi T; Nishiie H; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1742-6. PubMed ID: 3219152
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration.
Nakamura A; Hirota T; Sugihara K; Watanabe S; Tougou K; Morino A; Ezumi Y; Takaichi M
Arzneimittelforschung; 1997 Feb; 47(2):160-8. PubMed ID: 9079235
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
[TBL] [Abstract][Full Text] [Related]
34. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
[TBL] [Abstract][Full Text] [Related]
36. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
37. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
[TBL] [Abstract][Full Text] [Related]
38. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
[TBL] [Abstract][Full Text] [Related]
39. Disposition and metabolism of [14C]sparfloxacin in the rat.
Matsunaga Y; Miyazaki H; Oh-e Y; Nambu K; Furukawa H; Yoshida K; Hashimoto M
Arzneimittelforschung; 1991 Jul; 41(7):747-59. PubMed ID: 1663354
[TBL] [Abstract][Full Text] [Related]
40. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):201-8. PubMed ID: 9079241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
